 Name: ___       Unit No:  ___  Admission Date: ___       Discharge Date:  ___  Date of Birth: ___       Sex:  F  Service: MEDICINE  Allergies: Procaine / Aspirin  Attending: ___.  Chief Complaint: s/p fall  Major Surgical or Invasive Procedure: None

 History of Present Illness: ___ year old woman with recently diagnosed mesothelioma who was recently admitted with nausea, generalized weakness and intermittent shooting pains following chemotherapy now represents to the ED with frequent falls (approximately five in last three days) and orthostasis at home. In ED ___ admits to some head and neck pain initially which subsequently resolved. She has no other speicific complaints. No fevers, chills, chest pain, or any other signs of acute illness. Pt states her diarrhoea has not recurred. She was noted to have stable vitals with bp of 119/70 on lying but positive orthostasis with bp down to 97/45 on standing. Physical exam revealed multiple bruises but no evidence of fracture. CT head and neck revealed no evidence of fracture of bleed. labs were stable at baseline. Pt lives with daughter who feels she is too weak to return home right now. She's therefore admitted for further care. . On the floor, patient was sitting comfortably without specific complaints. . Review of Systems: (+) Per HPI (-) Denies fever, chills, headache, rhinorrhea or congestion. Denies chest pain or tightness, palpitations. Denies cough, shortness of breath, or wheezes. Denies rashes or skin breakdown. No numbness/tingling in extremities. All other review of systems negative.  Past Medical History: Past Oncologic History: Pt's diagnosis was made from a thoracentesis during a hospitalization for arrhythmias/pneumonia in ___. A pleural fluid cell block showed malignant cells consistent with malignant mesothelioma. Tumour cell stains were positive for calretinin, WT-1, D2-40, CK ___ and focally positive for CEA, ___. She was started in ___ on Pemetrexed 500mg/m2 q3weeks; however, after 3 cycles she was noted to have disease progression. She was then started on ___ on Vinorelbine 30mg/m2. . Other Past Medical History: -AVNRT -NSAID-related gastritis -RIJ thrombophlebitis -hx Graves disease s/p XRT (___) -GERD  Social History: ___ Family History: Mother- MI ___ Father- TB ___- brother died of lung CA, sister w/ CAD +fmhx DM2 (Several members) 3 brothers with MI in early ______  Physical Exam: Vitals: T 97.3 BP 119/70 HR 70 R 18 96% on 2L NC Gen: Well appearing adult woman, no acute distress. HEENT: EOMI. MMM. Conjunctiva well pigmented. Normal oro/nasopharynx. Neck: Supple, without adenopathy or JVD. No tenderness with palpation. Chest: CTAB anterior and posterior. No wheezing/rhonchi/rales. Mild bibasilar crackles. Mild dullness to percussion in left lower lung fields. Cor: Normal S1, S2. RRR. No murmurs/gallops/rubs. Abdomen: Soft, non-tender and non-distended. +BS, no HSM. Obese. Extremity: Warm, without edema. 2+ DP pulses bilat. Neuro: Alert and oriented. CN ___ intact. Strength and sensation grossly intact although somewhat unsteady on her feet Access: PIV  Pertinent Results: CT Head without contrast ___: IMPRESSION: No intracranial hemorrhage or mass effect. Minimal opacification of the inferior tip of the left mastoid air cells, likely due to an inflammatory process. Chronic small vessel ischemic changes.

CT C-spine ___: IMPRESSION: 1. No fracture or subluxation. 2. Cervical spondylosis. 3. Emphysema with large left pleural effusion and unchanged right apical nodule.

CXR ___: IMPRESSION: Continued moderate-sized left pleural effusion with left basilar opacification, likely representing a combination of atelectasis and known pleural based masses/nodules, but infection is not excluded.

___ 02:48PM BLOOD WBC-5.2 RBC-4.13* Hgb-11.8* Hct-35.5* MCV-86 MCH-28.6 MCHC-33.4 RDW-15.4 Plt ___ ___ 05:35AM BLOOD WBC-5.6 RBC-4.13* Hgb-12.3 Hct-36.2 MCV-88 MCH-29.8 MCHC-34.0 RDW-14.5 Plt ___ ___ 02:48PM BLOOD Neuts-33* Bands-0 Lymphs-47* Monos-17* Eos-2 Baso-1 ___ 04:11PM BLOOD ___ PTT-28.5 ___ ___ 02:48PM BLOOD Glucose-114* UreaN-8 Creat-0.7 Na-139 K-3.9 Cl-102 HCO3-28 AnGap-13 ___ 05:35AM BLOOD Glucose-99 UreaN-4* Creat-0.7 Na-139 K-4.1 Cl-101 HCO3-31 AnGap-11 ___ 07:00AM BLOOD ALT-15 AST-17 AlkPhos-77 TotBili-0.3 ___ 07:00AM BLOOD Calcium-7.9* Phos-3.8 Mg-2.1 ___ 05:35AM BLOOD Calcium-9.0 Phos-3.6 Mg-2.0 ___ 02:49PM BLOOD Hgb-13.1 calcHCT-___ year old woman with recently diagnosed mesothelioma s/p Pametrexed who admitted s/p fall after poor PO's, weakness, and orthostasis.

# Orthostasis/Dehydration: This was felt to be ___ to poor oral intake and the patient was without evidence of infection or blood loss. She was rehydrated to good effect and without further episodes of falls. On further discussion with the patient, she declined physical rehabilitation and elected to return home with hospice and 24 hour care by her daughter and niece. 

# Mesothelioma/Pleural effusion: Patient with disease progression on Pametrexed and unable to tolerated further chemotherapy. After discussion with the patient and her family, she elected to return home with hospice and was discharged to home under the care of her daughter.

 Medications on Admission: Aspirin EC 81 mg PO DAILY FoLIC Acid 1 mg PO/NG DAILY Benzonatate 100 mg PO BID Citalopram Hydrobromide 20 mg PO/NG DAILY Lorazepam 1 mg PO/NG HS Codeine Sulfate 30 mg PO/NG HS Diltiazem Extended-Release 180 mg PO DAILY Senna 1 TAB PO/NG BID:PRN constipation Enoxaparin Sodium 120 mg SC Q 24H Ondansetron ODT 8 mg PO/NG Q8H:PRN nausea Docusate Sodium 100 mg PO BID:PRN constipation Lorazepam 0.5 mg PO/NG Q6H:PRN anxiety  Discharge Medications: 1. Docusate Sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 times a day) as needed for constipation.  2. Lorazepam 0.5 mg Tablet Sig: One (1) Tablet PO Q6H (every 6 hours) as needed for anxiety, insomnia, nausea.  3. Folic Acid 1 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 

4. Aspirin 81 mg Tablet, Chewable Sig: One (1) Tablet, Chewable PO DAILY (Daily).  5. Citalopram 20 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).  6. Codeine Sulfate 30 mg Tablet Sig: One (1) Tablet PO HS (at bedtime).  7. Benzonatate 100 mg Capsule Sig: One (1) Capsule PO BID (2 times a day) as needed for cough.  8. Diltiazem HCl 180 mg Capsule, Sustained Release Sig: One (1) Capsule, Sustained Release PO DAILY (Daily).  9. Enoxaparin 120 mg/0.8 mL Syringe Sig: One Hundred Twenty (120) mg Subcutaneous DAILY (Daily). 

 Discharge Disposition: Home With Service  Facility: ___  Discharge Diagnosis: Primary: Orthostasis causing multiple falls Secondary: Mesothelioma

 Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent.

 Discharge Instructions: You were admitted to the hospital after several falls brought on from poor nutrition and dehydration. In the hospital, you determined that you would prefer not to receive further chemotherapy, so you are being discharged to home with a plan to establish supportive care with hospice.  Followup Instructions: ___ 